Live Breaking News & Updates on மருத்துவ நோக்கங்களுக்காக உரிமம்

Stay updated with breaking news from மருத்துவ நோக்கங்களுக்காக உரிமம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Canntab Announces the Early Exercise of $1,259,250 Warrants

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and. ....

Larry Latowsky , Company Or Canntab , Canntab Therapeutics Limited , Cannabis Research , Frankfurt Stock Exchange , Canntab Therapeutics , Neither The Canadian Securities Exchange , Canadian Securities Exchange , Health Canada , Therapeutics Limited , Cannabis Standard Processing , Medical Purposes License , Cannabis Research License , Industrial Hemp License , Market Regulator , கஞ்சா ஆராய்ச்சி , பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் , இல்லை தி கனடியன் பத்திரங்கள் பரிமாற்றம் , கனடியன் பத்திரங்கள் பரிமாற்றம் , ஆரோக்கியம் கனடா , சிகிச்சை வரையறுக்கப்பட்டவை , கஞ்சா தரநிலை ப்ரோஸெஸிஂக் , மருத்துவ நோக்கங்களுக்காக உரிமம் , கஞ்சா ஆராய்ச்சி உரிமம் , தொழில்துறை சணல் உரிமம் , சந்தை சீராக்கி ,

Canntab Granted 3rd Patent and Receives $400K Purchase Order in Australia

/CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene. ....

United States , Gavin Bogle , Richard Goldstein , Frank Candido , Larry Latowsky , Althea Group Holdings , Bogle Ohara , Australia Largest Observational Medical Cannabis Research Study , Company Or Canntab , Canntab Therapeutics Limited , Australian Patent Office Ip Australia , Neither The Canadian Securities Exchange , Cannabis Research Observational Study Applied , Canadian Securities Exchange , Cann Global Limited Purchase Order , Australian Patent Office , Australia Largest Cannabis Research Study , Cann Global Limited Of Australia , Cann Global , Australian Government Department Of Health , Cannabis Research , Canntab Therapeutics , Frankfurt Stock Exchange , Cymra Life Sciences , Health Canada , Global Ltd ,

Canntab Granted 3rd Patent and Receives $400K Purchase Order in Australia

Canntab Granted 3rd Patent and Receives $400K Purchase Order in Australia
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Gavin Bogle , Larry Latowsky , Althea Group Holdings , Bogle Ohara , Australia Largest Observational Medical Cannabis Research Study , Company Or Canntab , Canntab Therapeutics Limited , Australian Patent Office Ip Australia , Neither The Canadian Securities Exchange , Cannabis Research Observational Study Applied , Canadian Securities Exchange , Cann Global Limited Purchase Order , Australian Patent Office , Australia Largest Cannabis Research Study , Cann Global Limited Of Australia , Cann Global , Australian Government Department Of Health , Cannabis Research , Frankfurt Stock Exchange , Cymra Life Sciences , Health Canada , Australian Stock Exchange , Global Ltd , Patent Grant , Australian Purchase Order ,

Canntab Therapeutics Limited: Canntab Fulfills 80% of Its Contract with MediPharm Labs Corp.

Canntab Therapeutics Limited: Canntab Fulfills 80% of Its Contract with MediPharm Labs Corp.
Company or
Canntab ), the leading innovator in cannabinoid and terpene blends in hard pill form for medical and therapeutic applications, is pleased to announce that it has completed its 2
nd (second) delivery of (2) (two) additional SKU s ordered by MediPharm Labs Corp ( MediPharm Labs ) (TSX: LABS) (OTCQX: MEDIF) including 12.5mg CBD caplets (hard tablets in the shape of capsules) and 25mg CBD caplets for approximately $550,000.00. Canntab has now fulfilled 80% of the purchase amount contracted under the wholesale table purchase agreement entered into by the Company and MediPharm Labs in June, 2020. ....

United States , Frank Candido , Larry Latowsky , Canntab Therapeutics Inc , Company Or Canntab , Canntab Therapeutics Limited , Canntab Therapeutics Limited Larry Latowsky , Canntab Therapeutics Limited Richard Goldstein , Cannabis Research Licence , Neither The Canadian Securities Exchange , Clinical Research Organization , Medipharm Labs Corp , Canadian Securities Exchange , Frankfurt Stock Exchange , Newsfile Corp , Investor Relations Canntab Therapeutics , Health Canada , Business Development , Therapeutics Limited , Medipharm Labs , Chief Executive Officer , Canntab Therapeutics , Canadian Licensed Producer , Cannabis Standard Processing , Medical Purposes Licence , Industrial Hemp Licence ,

Canntab Therapeutics Limited: Canntab Engages Independent Trading Group for Market Making Services

Canntab Therapeutics Limited: Canntab Engages Independent Trading Group for Market Making Services
Company or
Canntab ), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announced today that it has engaged Independent Trading Group Inc. (
ITG ) to provide market-making services to the Company. ITG will trade the Company s common shares (the
Common Shares ) on the Canadian Securities Exchange (the
CSE ) and other marketplaces, as applicable, with the objective of maintaining a reasonable market and improving the liquidity of the Common Shares.
Pursuant to the terms of a services agreement (the
Services Agreement ), ITG will receive compensation of C$5,000 per month (plus applicable taxes), payable on the first business day of each month, for an initial term of three months, with services commencing on February 11, 2021. The Services Agreement will automatically renew for additional one-month ....

Richard Goldstein , Frank Candido , Larry Latowsky , Services Agreement , Trading Group Inc , Company Or Canntab , Canntab Therapeutics Limited , Cannabis Research , Frankfurt Stock Exchange , Canntab Therapeutics , Newsfile Corp , Health Canada , Canadian Securities Exchange , Business Development , Therapeutics Limited , Independent Trading Group , Common Shares , Cannabis Standard Processing , Medical Purposes License , Cannabis Research License , Industrial Hemp License , Chief Executive Officer , Chief Financial Officer , Investor Relations , ரிச்சர்ட் கோல்ட்ஸ்டைன் , வெளிப்படையான கேண்டிடோ ,